- What Are The Requirements For Storage Location Of Information Backup And Filing?
- Is It Necessary To Do Information Back Up And Filing By Using The Published Data Of Human Genetic Resources?
- An International Cooperative Clinical Study Is Divided Into Two Applications: Registration And Exploratory. Does It Need To Apply For Backup And Filing Separately For The Outbound Data Information?
- If The Project Data Is Submitted To Other National Administrative Departments In Stages, Is It Necessary To Apply Information Back Up And Filing?
- If There Are Different Receivers, Does The Information Need To Be Backed Up And Filed Separately?
- How Should The Real-time Outbound Data Information Be Backed Up And Filed?
- When Should Do Information Back Up And Filing In Case Of The Published Articles That Involve The Open Use Of Human Genetic Resources Information?
- Can The Foreign Entity Be The Applicant For Information Backup And Filing?
- Can The End Time Of External Provision Of Information Backup And Filing Be Later Than The Deadline Of International Cooperation?
- For An International Cooperative Clinical Trial, If The Summary Report Or Other Trial Data Provided To Other Entities (Chinese Entities) Other Than The Cooperative Parties, Whether Is It Open For Use, Or Need Do Information Backup And Filing?
- If The Data Statistics Company Needs To Receive The Information Of Human Genetic Resources, Does It Need To Do Information Back Up And Filing?
- How To Do Information Back Up And Filing When Overseas Publishing Or Participating In International Conferences Involving The Open Use Of Human Genetic Resources Information?
Strategy Consulting
- Market Entry Strategy
- Regulatory Strategy
- Clinical Strategy
- China Localization Strategy
- Hainan Urgent Use Pathway
- Innovation Pathway
- Fast Track Pathway
- Digital Health Consulting
Registration Affairs
- Pre-market Registration
- Modification Registration
- Renewal Registration
- Request for Classification
- Legal Agent Representation
- NMPA Expert Panel Meeting
- NMPA Supplemental Notice
Quality Assurance
- Postmarket Surveillance Compliance (IFU, Label, GSP)
- Adverse Event Reporting
- Recall Handling
- Periodic Risk Evaluation Report
- Annual QMS Self-Inspection Report
- NMPA Inspections & Mock-Audit
- QMS Establishment/Audit/Remediation
- QA Gap Analysis
- Factory Audit
- Unique Device Identifier
Device Testing
- China Local Type Testing
- Device Modification Compliance Testing
- Biocompatibility Testing
- EMC Testing
Clinical Research Organization (CRO)
- Clinical Trials/Research
- Real-World Study
- China CER & MDR CER
- Clinical Evaluation Feasibility Assessment
Customized Training
- China Regulatory Training
- China QMS Training
- China GCP Training
- China Localization Training
- Periodic Regulatory Updates Training
Other Services
- Translation
- Patent & Trademark
- Distributor Evaluation & Audit
- KOL Interview/Consultation
- Investment
- Global regulatory services
